M. Hoffmann et al., Recombinant Semliki Forest virus for over-expression and pharmacological characterisation of the histamine H-2 receptor in mammalian cells, EUR J PHARM, 427(2), 2001, pp. 105-114
We describe the use of recombinant Semliki Forest virus (SFV) vectors for e
fficient expression of the rat histamine H-2 (rH(2)) receptor in COS-7 (Afr
ican green monkey kidney cells) cells. Recombinant SFV-infected COS-7 cells
express the histamine rH(2) receptor in a time-dependent fashion with a ma
ximum expression level of 50 pmol mg(-1) after 40 h. SFV-mediated histamine
rH(2) receptor expression shows similar pharmacological properties as the
receptor expressed transiently or stably in mammalian cells. In addition, w
e demonstrate the pharmacological and functional characterisation of the (D
N)-N-115 mutated histamine rH(2) receptor. It has been shown that the (DN)-
N-115 mutation renders the receptor constitutively active and structurally
unstable. The rapid onset of and high maximal expression levels obtained fr
om SFV-infected COS-7 cells enabled us to characterise this mutant receptor
. We prove that recombinant SFV vectors are powerful tools for heterologous
expression of G-protein-coupled receptors and that one can achieve both th
e high-level gene expression described for baculovirus-infected insect cell
s and the use of mammalian cells as hosts. (C) 2001 Elsevier Science B.V. A
ll rights reserved.